PROCEPT BioRobotics Corp. (PRCT)
23.51
+0.17
(+0.73%)
USD |
NASDAQ |
Nov 12, 16:00
23.55
+0.04
(+0.17%)
After-Hours: 20:00
PROCEPT BioRobotics Free Cash Flow (Quarterly) : -9.652M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -9.652M |
| June 30, 2026 | -22.20M |
| March 31, 2026 | -41.04M |
| December 31, 2025 | -12.18M |
| September 30, 2025 | -9.503M |
| June 30, 2025 | -17.84M |
| March 31, 2025 | -18.82M |
| December 31, 2024 | -33.56M |
| September 30, 2024 | -19.05M |
| June 30, 2024 | -16.78M |
| March 31, 2024 | -34.23M |
| December 31, 2023 | -33.51M |
| Date | Value |
|---|---|
| September 30, 2023 | -24.72M |
| June 30, 2023 | -33.71M |
| March 31, 2023 | -41.27M |
| December 31, 2022 | -26.04M |
| September 30, 2022 | -21.36M |
| June 30, 2022 | -17.34M |
| March 31, 2022 | -18.29M |
| December 31, 2021 | -16.81M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -15.24M |
| December 31, 2020 | -13.45M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Insulet Corp. | 61.50M |
| Beta Bionics, Inc. | -14.56M |
| Abbott Laboratories | 1.224B |
| Baxter International, Inc. | 448.00M |
| Becton, Dickinson & Co. | 1.162B |